• Mashup Score: 0

    May 2022 | ASH Clinical News | American Society of Hematology May 2022 Managing the Fallout Hematologists are key players in radiologic emergency response, applying lessons learned from hematologic cancer and bone marrow transplants to the treatment of acute radiation syndrome.   Viewpoints Editor’s Corner The Most Powerful Drug A Day in the Life The COVID-Based Hematologist:…

    Tweet Tweets with this article
    • The May issue is out now! Click below to read about the role of #hematologists in #nuclear disasters, tips on giving your best talk, and the latest in #clinical news and studies https://t.co/rU6ebHhUBy https://t.co/A0kpeaFzl4

  • Mashup Score: 2

    In this edition of “From the Desk Of…,” ASH Clinical News Editor-in-Chief Aaron Gerds, MD, previews the forthcoming May 2022 issue. Highlights include a fe…

    Tweet Tweets with this article
    • Preview our May 2022 issue with Editor-in-Chief @AaronGerds, MD. Highlights include a feature on the role of #hematologists in #radiologic disasters, tips on giving your best lecture, and more. Stay tuned for the issue’s publication on May 4! https://t.co/Tkm3Kl1J5F

  • Mashup Score: 6

    Explore ASH’s SCD priorities, and discover the steps the Society has taken and continues to explore to make a significant difference in SCD access to care, research, and global issues.

    Tweet Tweets with this article
    • Today is #RareDiseaseDay! ASH is proud to support #hematologists around the world who are working to conquer blood diseases like #sicklecell disease. Learn about our work https://t.co/gARL6qpUfl https://t.co/BVXZC17URx

  • Mashup Score: 0
    Wolters Kluwer Health - 2 year(s) ago

    JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable…

    Tweet Tweets with this article
    • Recent research highlighted differences in the opinions of #hematologists and #palliative care physicians when it comes to the indication for undergoing transfusion therapy among patients with end-stage hematological malignancies: https://t.co/FBShILxoxg #hemonc #PallOnc https://t.co/h4NLhKQvFc

  • Mashup Score: 0
    Wolters Kluwer Health - 2 year(s) ago

    JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable…

    Tweet Tweets with this article
    • Recent research highlighted differences in the opinions of #hematologists and #palliativecare physicians when it comes to the indication for undergoing #transfusiontherapy among patients with end-stage hematological malignancies: https://t.co/moaHV5QpZq https://t.co/vXkcWsXnPX

  • Mashup Score: 0
    Wolters Kluwer Health - 2 year(s) ago

    JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable…

    Tweet Tweets with this article
    • Recent research highlighted differences in the opinions of #hematologists and #palliativecare physicians when it comes to the indication for undergoing #transfusiontherapy among patients with end-stage hematological malignancies: https://t.co/a3FRYtDSki #hemonc https://t.co/k1jh4hbqKb

  • Mashup Score: 0
    Subscribe - EMJ - 3 year(s) ago

    Complete the form below to receive our free quarterly newsletters, journal publication alerts, and other relevant content for the therapeutic areas…

    Tweet Tweets with this article
    • Are you looking for the latest hematology content? When you subscribe to EMJ Hematology, you will receive unrestricted access to the latest news and updates from the field. Subscribe for free today: https://t.co/FlMQPNF8KQ #Hematologists #Anemia #Redbloodcell #Blooddisorder https://t.co/TR8zkolUO0